The application of PDTC to the Her2-amplified breast cancer cell line SKBR3 induces inhibition of the IκB ubiquitin ligase resulting in an enhanced interaction of PTPIP51 and RelA. This evidence concerns the gene ERBB2 and breast carcinoma.